tigecycline (Tygacil) for community-acquired pneumonia (CAP)

Reps will be promoting tigecycline (Tygacil) for community-acquired pneumonia (CAP).

It's now approved for this use in hospitalized patients who aren't in the ICU...but it's usually not the best choice.

The usual empiric therapy for these patients is monotherapy with levofloxacin or moxifloxacin...or a combination of a beta-lactam plus macrolide.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote